| Literature DB >> 34004179 |
Dimitri Meistermann1, Alexandre Bruneau2, Sophie Loubersac3, Arnaud Reignier3, Julie Firmin3, Valentin François-Campion2, Stéphanie Kilens2, Yohann Lelièvre4, Jenna Lammers5, Magalie Feyeux6, Phillipe Hulin7, Steven Nedellec7, Betty Bretin2, Gaël Castel2, Nicolas Allègre8, Simon Covin2, Audrey Bihouée9, Magali Soumillon10, Tarjei Mikkelsen10, Paul Barrière3, Claire Chazaud8, Joel Chappell11, Vincent Pasque11, Jérémie Bourdon4, Thomas Fréour12, Laurent David13.
Abstract
Understanding lineage specification during human pre-implantation development is a gateway to improving assisted reproductive technologies and stem cell research. Here we employ pseudotime analysis of single-cell RNA sequencing (scRNA-seq) data to reconstruct early mouse and human embryo development. Using time-lapse imaging of annotated embryos, we provide an integrated, ordered, and continuous analysis of transcriptomics changes throughout human development. We reveal that human trophectoderm/inner cell mass transcriptomes diverge at the transition from the B2 to the B3 blastocyst stage, just before blastocyst expansion. We explore the dynamics of the fate markers IFI16 and GATA4 and show that they gradually become mutually exclusive upon establishment of epiblast and primitive endoderm fates, respectively. We also provide evidence that NR2F2 marks trophectoderm maturation, initiating from the polar side, and subsequently spreads to all cells after implantation. Our study pinpoints the precise timing of lineage specification events in the human embryo and identifies transcriptomics hallmarks and cell fate markers.Entities:
Keywords: blastocyst; cell fate; epiblast; human embryo; lineage specification; pluripotency; preimplantation development; pseudotime; scRNA-seq; trophectoderm
Year: 2021 PMID: 34004179 DOI: 10.1016/j.stem.2021.04.027
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633